The forecast for stomach malignant neoplasms mortality in Germany shows a consistent downward trend from 6.4 deaths per hundred thousand persons in 2024 to 5.5 in 2028. This indicates an annual reduction in standardized mortality rates, suggesting progressive improvements in healthcare interventions or early detection methodologies. The year-on-year variation highlights a decline of approximately 3.13% from 2024 to 2025, with the reduction continuing at a stable rate through 2028. The compound annual growth rate (CAGR) over these five years further confirms the sustained decrease, reflecting an average annual decline.
Future trends to watch for include advancements in medical technologies, treatment protocols, and public health initiatives that could accelerate the decline in mortality rates. Additionally, shifts in lifestyle factors, dietary patterns, and aging demographics in Germany may influence these trends and should be monitored closely to assess potential impacts on future mortality rates.
